DE · TED (EU)tender

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-29 - Omalizumab

Techniker Krankenkasse

481 days remaining — 31 Oct 2027
🤖

AI Summary

Win probability: 25%

Techniker Krankenkasse (Germany's largest health insurance fund) is seeking pharmaceutical suppliers for Omalizumab (a monoclonal antibody for asthma/allergies) under their collective discount agreement framework for 2025-2029. Eligible suppliers must be authorized pharmaceutical distributors or manufacturers meeting German/EU regulatory requirements for medicinal products. The contract represents significant volume potential given TK's ~10 million insured members, though specific pricing and volume commitments are not disclosed.

View & apply on TED (EU)

Applications are submitted on the official government portal. Minted Tenders helps you find and track opportunities — we don't process applications.

Details

Source
TED (EU)
Country
Germany
Type
Tender
Status
Active
Buyer
Techniker Krankenkasse
Deadline
31 Oct 2027
Sectors
supplies
View & apply on TED (EU)

Applications submitted on the official portal — not via Minted Tenders.